Financial Architects, Inc Abiomed Inc Transaction History

Financial Architects, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$224.73 - $338.64 $179,784 - $270,912	-800 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $107,159 - $121,669	-427 Reduced 34.8%	800 $208,000
Q1 2019 May 13, 2019	BUY	$276.39 - $362.25 $339,130 - $444,480	1,227 New	1,227 $350,000
Q1 2019 May 03, 2019	SELL	$276.39 - $362.25 $395,237 - $518,017	-1,430 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$281.08 - $444.25 $16,021 - $25,322	-57 Reduced 3.83%	1,430 $464,000
Q3 2018 Oct 29, 2018	BUY	$354.53 - $449.75 $7,090 - $8,995	20 Added 1.36%	1,487 $669,000
Q2 2018 Aug 03, 2018	SELL	$278.07 - $446.21 $148,211 - $237,829	-533 Reduced 26.65%	1,467 $600,000
Q3 2017 Nov 01, 2017	BUY	$145.39 - $168.6 $290,780 - $337,200	2,000	2,000 $337,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.